Community/Retail

According to the CDC, the ability to evade natural or vaccine-induced immunity could be the most concerning consequence of emerging variants.

Rather than having an intrinsically lower risk of severe COVID-19, the patients in the study may have adhered more strictly to social distancing guidelines compared to the general population.

The findings suggest pre-diagnosis aspirin use might help reduce CRC mortality in the overall population by limiting metastatic spread of colorectal tumors before diagnosis.

Previous research has found that exercise-induced changes in cognitive function might be mediated by activity in the dopaminergic system, which is known to be involved in physical activity and exercise.

Burnout often results from long hours, a highly regulated industry with a lot of change, and just the nature of health care in general.

COVID-19 antibody test may also be able to identify those who have been exposed to the disease but have so far been asymptomatic.

Pharmacy managers should offer access and incentivize pharmacy staff to take part in self-development activities that can promote self-efficacy.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what’s on the horizon of interest for independent pharmacy in 2021.

Helpful patient education suggestions for the successful management of COVID-19 at home and when it is appropriate to seek medical attention.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on his outlook for the future of independent community pharmacy.

The study authors found marked improvements in rates of hazardous prescribing over the 12-month study period and the success of the intervention was sustained at the end.

The COVID-19 pandemic has escalated the burden of psychological distress, including anxiety, depression, post-traumatic stress, and insomnia.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the steps necessary to support the long-term viability of independent community pharmacies.

The federal government also gave pharmacy technicians the authority to administer COVID-19 vaccines under the supervision of a pharmacist.

The participating national pharmacy partners and independent pharmacy networks represent more than 40,000 pharmacy locations and is a key component of the administration’s national strategy to expand access to vaccines.

When conducting a cesarean delivery, the use of a wound infusion pump in combination with enhanced recovery efforts was found to reduce opioid use by more than 80%.

Three international cardiovascular outcomes trials are currently examining the cardioprotective effects of different influenza vaccine formulations.

Stroke is not among the covered diagnoses for cardiac rehab, despite many similar cardiovascular risk factors, according to the study.

Radiologists should be aware of pulmonary artery thrombosis so that they can work with pharmacists to facilitate accurate diagnoses and management techniques.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on solutions that can help support independent community pharmacies now and in the future.

Pharmacy Times® interviewed Micah Cost, PharmD, MS, who was recently selected as the new chief executive officer of PQA, on his plans for the future of the organization.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.

Although eating healthier food and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.

Vaccine hesitancy is a main driver for lower than desired vaccination rates and recent outbreaks of vaccine-preventable illnesses, such as measles, in the United States.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what the implementation of the recent unanimous SCOTUS ruling on Rutledge v. PCMA may look like.

New data from an unreviewed, preprint research article indicate first-dose immunization efficacy of the Pfizer-BioNTech coronavirus 2019 vaccine improves by 51% 13-24 days post administration.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what proper screening and protection looks like for health care workers administering the COVID-19 vaccine looks like.

The letter said states where community pharmacists have taken a larger leadership role have seen a much faster distribution of COVID-19 vaccines to vulnerable populations.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.

The level of protection for the single-dose COVID-19 vaccine was 72% in the United States compared to 57% in South Africa at 28 days post-vaccination, suggesting lower efficacy against the emerging South African variant.